Uncategorized
Allegro Ophthalmics receives $10.7 million in private financing
Allegro Ophthalmics announced it has secured $10.7 million in a private round of equity financing. The additional capital will allow the company to complete several phase 2 clinical trials and help prepare for phase 3 studies in the future, Vicken Karageozian, MD, president and chief medical officer of Allegro, said in a press release.